|
Market Closed -
NSE India S.E.
15:05:10 13/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,027.20 INR | -1.30% |
|
+1.88% | +40.17% |
| Market Cap | 329B 3.49B 3.17B 2.93B 2.64B 4.98B 5.15B 35.18B 13.95B 176B 13.11B 12.83B 559B | P/E 2025 |
-472x | P/E 2026 | 89.7x |
|---|---|---|---|---|---|
| Enterprise Value | 345B 3.66B 3.32B 3.07B 2.77B 5.21B 5.4B 36.83B 14.61B 184B 13.73B 13.44B 585B | EV / Sales 2025 |
8.1x | EV / Sales 2026 | 5.97x |
| Free-Float |
48.99% | Yield 2025 * |
-
| Yield 2026 | - |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| WOCKPHARMA | Delayed | |
Bombay S.E.
| WOCKPHARMA | Delayed |
| 1 day | -1.30% | ||
| 1 week | +1.88% | ||
| Current month | +6.63% | ||
| 1 month | +3.26% | ||
| 3 months | +9.73% | ||
| 6 months | +29.09% | ||
| Current year | +40.17% |
| 1 week | 1,962 |  | 2,089 |
| 1 month | 1,772 | | 2,089 |
| Current year | 1,086.7 | | 2,422.3 |
| 1 year | 1,086.7 | | 2,422.3 |
| 3 years | 275.1 | | 2,422.3 |
| 5 years | 145.15 | | 2,422.3 |
| 10 years | 145.15 | | 2,422.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2009 | |
Deepak Madnani
DFI | Director of Finance/CFO | - | 01/03/2022 |
Mahesh V. Patel
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/1998 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 83 | 06/11/2009 | |
| Director/Board Member | 53 | 06/11/2009 | |
| Director/Board Member | 55 | 01/07/1996 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.30% | +1.88% | +49.04% | +688.95% | 3.55B | |
| +1.35% | +6.75% | +41.30% | +135.89% | 1,271B | |
| +0.97% | +3.64% | +46.62% | +93.91% | 683B | |
| +0.23% | +1.20% | +26.92% | +112.65% | 520B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 389B | |
| -0.22% | -0.16% | +57.65% | +42.97% | 362B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 304B | |
| +0.37% | +0.37% | +3.62% | +36.44% | 286B | |
| -0.24% | +1.13% | +38.57% | +74.58% | 253B | |
| +0.22% | +0.77% | +34.32% | +124.44% | 208B | |
| Average | +0.11% | +1.88% | +36.44% | +143.78% | 428B | |
| Weighted average by Cap. | +0.55% | +2.67% | +37.59% | +96.61% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 30.35B 322M 292M 270M 243M 459M 475M 3.24B 1.29B 16.21B 1.21B 1.18B 51.46B | 34.62B 367M 333M 308M 278M 523M 542M 3.7B 1.47B 18.49B 1.38B 1.35B 58.7B |
| Net income | -470M -4.98M -4.52M -4.18M -3.77M -7.1M -7.35M -50.19M -19.9M -251M -18.71M -18.31M -797M | 2.13B 22.59M 20.47M 18.93M 17.08M 32.19M 33.33M 227M 90.19M 1.14B 84.77M 82.98M 3.61B |
| Net Debt | 14.33B 152M 138M 127M 115M 217M 224M 1.53B 607M 7.65B 570M 558M 24.3B | 15.53B 165M 149M 138M 125M 235M 243M 1.66B 658M 8.3B 618M 605M 26.33B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | ₹2,027.20 | -1.30% | 392,517 |
| 12/11/26 | ₹2,054.00 | +0.95% | 342,889 |
| 11/11/26 | ₹2,034.60 | +0.15% | 436,260 |
| 09/11/26 | ₹2,031.50 | +1.26% | 896,543 |
| 08/11/26 | ₹2,006.30 | +3.05% | 229,973 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- WOCKPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
